The oral hypoglycemic agent, derived from sulfonylureas of the II generation. Used in complex therapy with insulin to control the blood glucose levels daily in diabetes of the second type. Has pancreatic and extrapancreatic effects. Stimulates the secretion of insulin by lowering the threshold of pancreas beta cells’ stimulation by glucose, improves insulin sensitivity and the degree of its binding to target cells, increases insulin release, enhances the effect the insulin has on glucose uptake by muscle and liver, inhibits lipolysis in the adipose tissue.